Investors and Australian life sciences company leaders met on the Gold Coast this week for AusBiotech Invest, a curated forum ...

Telix Pharmaceuticals has reaffirmed that it will pass US$1 billion in revenue and other income this year. Its third-quarter ...

Australia's life sciences sector has converged on the Gold Coast for what organiser AusBiotech describes as the event's ...

CSL has named Deborah Waterhouse, a British pharmaceutical executive who previously led GSK in Australia, as its next chief ...

BioNTech has opened its clinical-scale mRNA manufacturing and research facility at La Trobe University's Bundoora campus, ...

Today, AusBiotech Invest brings together investors and selected life sciences company leaders on the Gold Coast for a focused ...

Telix has partnered with a new Franco-Belgian venture to produce astatine-211 in the United States. The isotope is scarce but ...

Invion has closed recruitment for its first-in-human trial of a light-activated treatment for non-melanoma skin cancer. The ...

Island Pharmaceuticals will begin testing its antiviral Galidesivir against Marburg virus at a US Army laboratory this ...

Algorae Pharmaceuticals has signed two agreements with Mumbai-based manufacturer Umedica Laboratories. Together, they give the company's commercial arm access to a range of generic medicines for the ...

Researchers at Monash University have won more federal funding to keep studying how one of the immune system's brakes works.

Peter Mac's CAR T cell is made using an adeno-associated virus, or AAV, vector. VVMF will run an initial pilot study at ...